Avectas partners with Vycellix to speed cell therapy production 31-Mar-2020 By Ben Hargreaves The partners will combine expertise to progress the novel RNA immunomodulator, VY-M.
Avectas collaborates with CCRM on cell engineering tech 04-Mar-2020 By Ben Hargreaves The two partners will look to accelerate the development of Avectas’ Solupore platform for the development of immuno-oncology and gene therapies.